Biostage, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 10/06/2017
Contact Info
  • 84 October Hill Road
  • Suite 11
  • Holliston, MA 01746

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001563665
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 2012
Employees Not Available
Company Officers/Contacts
James McGorry CEO
Thomas McNaughton CFO
Jake Burgess Director, Fin.
Company Directors
John F. Kennedy Chairman
John Canepa
James McGorry
Blaine McKee
Thomas Robinson
Company Notes
  • Formerly=Harvard Apparatus Regenerative Technology, Inc. until 4-2016
Service Providers
Accounting/Auditing Firm
One Broadway
15th Floor
Cambridge, MA, 02142
United States

Legal Counsel
Burns & Levinson LLP
125 Summer Street
Boston, MA, 02110
United States

Investor Relations Firm
Russo Partners LLC
75 Ninth Avenue
New York, NY, 10011
United States

BSTG Security Details
Share Structure
Market Value1 $3,288,844 a/o Oct 20, 2017
Authorized Shares 120,000,000 a/o Oct 05, 2017
Outstanding Shares 39,787,615 a/o Oct 05, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 36,035,542 a/o Oct 05, 2017
Par Value Not Available
Transfer Agent(s)
Shareholders of Record 181 a/o Aug 14, 2017
Short Selling Data
Short Interest (%)
Significant Failures to Deliver No

1Market Value calculated only for respective security